Tim Welliver

Tim Welliver has extensive work experience in the field of medicine and clinical development. Tim most recently worked at Arcellx as a Clinical Development Senior Medical Director starting in August 2022. Prior to that, they were at ALX Oncology from October 2020 to August 2022, serving as a Clinical Development Medical Director. Before joining ALX Oncology, Tim worked at Amgen, where they held the positions of Clinical Development Medical Director from July 2019 to October 2020 and Medical Affairs from January 2018 to July 2019. Tim also has experience in Medical Affairs at Bristol-Myers Squibb from June 2015 to January 2018. Tim's educational background includes a Doctor of Medicine degree from Case Western Reserve University, where they studied from July 2011 to May 2015, and a PhD in Immunology from the University of Michigan Health System, where they studied from July 2007 to June 2011.

Tim Welliver completed their Doctor of Medicine (M.D.) degree at Case Western Reserve University School of Medicine from 2011 to 2015. Prior to that, they obtained a Doctor of Philosophy (PhD) in Immunology from the University of Michigan Medical School, graduating between 2007 and 2011.